Anne Baker, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14500 E 42nd St S Ste 220, Independence, MO 64055 Phone: 816-478-7800 Fax: 816-478-7839 |
Ashton Doza Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14500 E 42nd St S Ste 220, Independence, MO 64055 Phone: 816-478-7800 Fax: 816-478-7839 |
Michelle Armilio, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2101 N. Twyman Road, Independence, MO 64058 Phone: 816-650-7440 |
Hailee Arnold, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2101 N Twyman Rd, Independence, MO 64058 Phone: 816-507-0218 |
Ms. Karen Kay Moyer, MA SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3225 S Noland Rd, Independence, MO 64055 Phone: 816-521-5300 Fax: 816-521-2999 |
Adriana Dimon Arabas, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14820 E 42nd St S, Independence, MO 64055 Phone: 816-695-1255 |
News Archive
Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis. With these clinical features at his side, he turns to the basic building blocks of life , the human genome , to figure out what makes these people susceptible to the disabling inflammatory condition.
Scientists are proposing an international effort, on the scale of the Human Genome Project (HGP), to identify all the proteins present in cancer cells. HGP was the international scientific research project that identified and mapped all the genes in humans.
Despite the prestige of becoming a physician, 80 percent of medical students report a low sense of personal achievement, according to a new study in The Journal of the American Osteopathic Association.
A new study has uncovered an increased risk of dementia-in particular Alzheimer's disease-in patients with rosacea. Importantly, the risk was highest in older patients and in patients where rosacea was diagnosed by a hospital dermatologist. The findings are published in the Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial.
› Verified 6 days ago